jardiance vs glp 1 Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study GLP-1 Medications for Weight Loss:

& Samaha, A

2021;3(3) doi: 10.1016/j.jhepr.2021.100256

15 Diabetes is regarded as an independent risk factor for pill-induced oesophagitis, which occurs due to the delayed transit of medication through the oesophagus as a result of impaired oesophageal motility, leading to prolonged exposure of the oesophagus to the medication

Theres typically strict criteria for who can be approved for these medications for weight loss purposes

Other common structural changes include aortic stenosis, myocardial fibrosis and myocyte stiffness

The use of GLP-1RA is rapidly growing, with global spending around $24 billion last year and some estimates propose global spending could reach $131 billion by 2028 (47)